These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 3140844)
1. The early effects of a single application of acetone and various doses of 7,12-dimethylbenz(alpha)anthracene on CD-1 and hairless mouse epidermis. A cell kinetic study of so-called initiation and complete carcinogenesis (initiation plus promotion) in chemical skin tumor induction. Iversen OH; Ljunggren S; Olsen WM APMIS Suppl; 1988; 2():7-80. PubMed ID: 3140844 [TBL] [Abstract][Full Text] [Related]
2. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
3. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302 [TBL] [Abstract][Full Text] [Related]
5. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of o-Phenylphenol (CAS No. 90-43-7) Alone and with 7,12-Dimethylbenz(a)anthracene (CAS No. 57-97-6) in Swiss CD-1 Mice (Dermal Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1986 Mar; 301():1-141. PubMed ID: 12748705 [TBL] [Abstract][Full Text] [Related]
7. Tumorigenesis and carcinogenesis studies of a number of insulation oils and fluids on hairless and SENCAR mice with special reference to skin tumours and malignant lymphomas. Iversen OH APMIS Suppl; 1990; 13():1-60. PubMed ID: 2357397 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020 [TBL] [Abstract][Full Text] [Related]
9. Cell kinetic effects of low doses of the skin carcinogen 7,12-dimethylbenz[a]anthracene on hairless mouse epidermis. Olsen WM; Iversen OH Carcinogenesis; 1987 Oct; 8(10):1411-5. PubMed ID: 3115612 [TBL] [Abstract][Full Text] [Related]
10. The reverse experiment in two-stage skin carcinogenesis. It cannot be genuinely performed, but when approximated, it is not innocuous. Iversen OH APMIS Suppl; 1993; 34():1-96. PubMed ID: 8251199 [TBL] [Abstract][Full Text] [Related]
11. Distribution of covalent DNA adducts in mouse epidermal subpopulations after topical application of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene. Baer-Dubowska W; Morris RJ; Gill RD; DiGiovanni J Cancer Res; 1990 May; 50(10):3048-54. PubMed ID: 2110503 [TBL] [Abstract][Full Text] [Related]
12. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis. Smolarek TA; Baird WM; Fisher EP; DiGiovanni J Cancer Res; 1987 Jul; 47(14):3701-6. PubMed ID: 3109730 [TBL] [Abstract][Full Text] [Related]
13. The skin tumorigenic and carcinogenic effects of different doses, numbers of dose fractions and concentrations of 7,12-dimethylbenz[a]anthracene in acetone applied on hairless mouse epidermis. Possible implications for human carcinogenesis. Iversen OH Carcinogenesis; 1991 Mar; 12(3):493-502. PubMed ID: 1901252 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
15. Promoter independence as a feature of most skin papillomas in SENCAR mice. Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044 [TBL] [Abstract][Full Text] [Related]
16. Epidermal changes following application of 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate to human skin transplanted to nude mice studied with histological species markers. Graem N Cancer Res; 1986 Jan; 46(1):278-84. PubMed ID: 3079587 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
18. Transplacental skin tumor initiation of Ha/ICR mice at different fetal ages. Morris EP; Burns FJ; Albert RE Cancer Res; 1983 Sep; 43(9):4271-4. PubMed ID: 6409402 [TBL] [Abstract][Full Text] [Related]
19. A diurnal variation in the tumorigenic response of mouse epidermis to a single application of the strong short-acting chemical carcinogen methylnitrosourea. A dose-response study of 1, 2 and 10 mg. Iversen OH; Iversen UM In Vivo; 1995; 9(2):117-32. PubMed ID: 7548787 [TBL] [Abstract][Full Text] [Related]
20. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]